SCHEMBL1149232

SCHEMBL1149232

O=[N+]([O-])c1ccc(Sc2ccc(Cl)cc2)c(Cl)c1

nearest known ligand 0.78

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 13/20 0.78
PDE7B Q9NP56 4/20 0.73
PDE4B Q07343 2/20 0.73
PDE4D Q08499 2/20 0.73
HSD17B10 Q99714 1/20 0.53
LMNA P02545 2/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
TXNRD1 Q16881 1/20 0.49
TXNRD3 Q86VQ6 1/20 0.49
TXNRD2 Q9NNW7 1/20 0.49
USP2 O75604 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
ALPG P10696 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PLA2G4A P47712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23407733 0.90 PDE7A (0.68) PDE7APDE7BPDE4BPDE4DMEN1
SCHEMBL8308859 0.87 PDE7A (1.00) PDE7APDE7BPDE4BPDE4DHSD17B10
SCHEMBL7605579 0.87 PDE7A (0.67) PDE7APDE7BPDE4BPDE4DHSD17B10
SCHEMBL27581742 0.86 PDE7A (0.75) PDE7APDE7BPDE4BPDE4DHSD17B10
SCHEMBL27561251 0.86 TXNRD1 (0.70) PDE7APDE7BPDE4BPDE4DTXNRD1
SCHEMBL7608814 0.86 PDE7A (0.71) PDE7APDE7BPDE4BPDE4DHSD17B10
SCHEMBL715750 0.84 PDE7A (1.00) PDE7APDE7BPDE4BPDE4DHSD17B10
SCHEMBL28325601 0.84 PDE7A (0.57) PDE7APDE7BPDE4BPDE4DMEN1
SCHEMBL3029788 0.84 PDE7A (0.68) PDE7APDE7BPDE4BPDE4DHSD17B10
SCHEMBL10924255 0.83 PDE7A (0.76) PDE7APDE7BPDE4BPDE4DHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1780202-B1 QUINOLINE DERIVATIVE AND INSECTICIDE CONTAINING SAME AS ACTIVE CONSTITUENT MEIJI SEIKA PHARMA CO LTD (JP) 2013-02-27 EP disclosed
US-7880006-B2 4-Acetoxy-5-chloro-6-(4-chlorophenoxy)-2,3-dimethyl-quinoline, used as agricultural and horticultural insecticides MEIJI SEIKA KAISHA, LTD. (JP) 2011-02-01 US disclosed
US-20070203181-A1 Quinoline Derivatives And Insecticide Comprising Thereof As Active Ingredient MEIJI SEIKA KAISHA, LTD. (JP) 2007-08-30 US disclosed
EP-1780202-A1 QUINOLINE DERIVATIVE AND INSECTICIDE CONTAINING SAME AS ACTIVE CONSTITUENT MEIJI SEIKA KAISHA LTD. (JP) 2007-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203181-A1 Quinoline Derivatives And Insecticide Comprising Thereof As Active Ingredient DDT, ACHE, NQO1 PDE7A 198/4885PDE7B 116/4885PDE4B 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.